Only uEVs from patients with advanced stages of ADPKD had increased levels of villin-1, periplakin, and envoplakin, whereas uEVs from young patients with ADPKD and preserved kidney function already had higher levels of complement [110]. This evidence concerns the gene PPL and autosomal dominant polycystic kidney disease.